RxSight
$6.59
22
+$0.25+3.94% Today
Statistics
Day High
6.7
Day Low
6.13
52W High
26.56
52W Low
6.09
Volume
263,409
Avg. Volume
970,957
Mkt Cap
271.94M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MayExpected
Expected EPS
-0.30875
Actual EPS
N/A
Financials
-28.96%Profit Margin
Unprofitable268.96MRevenue
-77.89MNet Income
Analyst Ratings
$10.00Average Price Target
The highest estimate is 13.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 14%
Hold 71%
Sell 14%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow RXST. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Alcon
ALC
Mkt Cap36.88B
Staar Surgical
STAA
Mkt Cap1.28B
Cooper Companies
COO
Mkt Cap13.9B
Bausch Health Companies
BHC
Mkt Cap2.62B
Integra Lifesciences
IART
Mkt Cap935.48M
Novo Nordisk
NVO
Mkt Cap217.54B
Abbvie
ABBV
Mkt Cap385.18B
About
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Show more...
CEO
Dr. Ronald M. Kurtz M.D.
Employees
498
Country
US
ISIN
US78349D1072
Listings
0 Comments
Share your thoughts
FAQ
What is RxSight stock price today?▼
The current price of RXST is $6.59 USD — it has increased by +3.94% in the past 24 hours. Watch RxSight stock price performance more closely on the chart.
What is RxSight stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange RxSight stocks are traded under the ticker RXST.
Is RxSight stock price growing?▼
RXST stock has risen by +1.54% compared to the previous week, the month change is a -13.4% fall, over the last year RxSight has showed a -74.77% decrease.
What is RxSight market cap?▼
Today RxSight has the market capitalization of 271.94M
When is the next RxSight earnings date?▼
RxSight is going to release the next earnings report on May 12, 2026.
What were RxSight earnings last quarter?▼
RXST earnings for the last quarter are -0.22 USD per share, whereas the estimation was -0.33 USD resulting in a +34.27% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RxSight revenue for the last year?▼
RxSight revenue for the last year amounts to 268.96M USD.
What is RxSight net income for the last year?▼
RXST net income for the last year is -77.89M USD.
How many employees does RxSight have?▼
As of April 02, 2026, the company has 498 employees.
In which sector is RxSight located?▼
RxSight operates in the Health Care sector.
When did RxSight complete a stock split?▼
The last stock split for RxSight was on September 21, 2006 with a ratio of 9:1.
Where is RxSight headquartered?▼
RxSight is headquartered in Aliso Viejo, US.